General
Lupin Neurosciences está comprometida a trabajar con los profesionales sanitarios en el desarrollo de soluciones basadas en la ciencia que se extiendan allá del acceso del paciente a opciones de tratamiento que cambien su vida y optimicen la atención en enfermedades neurológicas médicamente no cubiertas.
2024 Congress
IDMC -14: The 14th International Myotonic Dystrophy Consortium Meeting, 09-13 April 2024, Nijmegen, The Netherlands
- Age, family history and genetic testing data from myotonic dystrophy patients and carers participating in ENSA survey
- ENSA:RevEal the burdeN on daily life for myotonic dyStrophy patients due to myotoniA: key findings of the ENSA survey
- Patient reported satisfaction in myotonic dystrophy management: ENSA international survey suggests benefits of Italian routine practice
8th International Myology Congress, 22-25 April, 2024, Paris, France
- RevEal the burdeN on daily life for myotonic dyStrophy patients due to myotoniA: preliminary results of the ENSA survey
- Expert insights: A Delphi-driven neurologists’ panel: real-world mexiletine use in patients with myotonic disorders in Italy
- Development of an auto-questionnaire to measure the impact of non-dystrophic myotonia on patients’ daily lives